BKHAR (BKHAR)

AI-Powered SEC Filing Analysis

Quarterly Report Filed: 2026-04-21

Key Insights

Black Hawk Acquisition Corp remains a shell company as of the Q1 2026 filing date, indicating no business combination has been completed yet despite the company being operational since October 2023.
The company is a smaller reporting company and emerging growth company, which provides reduced regulatory compliance burdens but signals limited operational scale and market capitalization.
Multiple share classes (Class A and Class B ordinary shares) and complex warrant/right structures suggest a typical SPAC structure with founder shares, IPO proceeds, and over-allotment options still in place.
The filing shows continued compliance with SEC reporting requirements and interactive data submissions, indicating the company remains in good regulatory standing during its search for an acquisition target.

Current Report Filed: 2026-04-01

Key Insights

Black Hawk Acquisition Corporation has received a notice from Nasdaq stating that its market value of listed securities (MVLS) has fallen below the $50 million requirement for continued listing on the Nasdaq Global Market.
The company has 180 days to regain compliance with the MVLS requirement, which can be achieved by maintaining a MVLS of $50 million or more for a minimum of 10 consecutive business days.
If the company fails to regain compliance within the allotted time, it may consider applying to transfer the listing of its securities to the Nasdaq Capital Market, provided it meets the requirements for continued listing on that market.

Current Report Filed: 2026-03-17

Key Insights

Black Hawk Acquisition Corp has announced the appointment of Michael Tolentino as the new CEO of its proposed business combination target, Vesicor Therapeutics, Inc.
The employment agreement with Tolentino provides details on his compensation, termination provisions, and non-compete restrictions, which are important for understanding the leadership transition.
Tolentino has a strong background as a serial entrepreneur, retinal surgeon, and biotechnology executive, which could benefit Vesicor's development pipeline and future prospects.

Annual Report Filed: 2026-03-06

Key Insights

Black Hawk Acquisition Corp is a newly formed special purpose acquisition company (SPAC) that has not yet completed an initial business combination.
The company raised $200 million in its IPO in March 2024 and has 24 months to complete a merger or acquisition transaction.
As of November 30, 2025, the company has $200 million in cash and cash equivalents on its balance sheet, indicating it has not yet deployed its IPO proceeds.

Current Report Filed: 2026-02-19

Key Insights

Black Hawk Acquisition Corp. issued a $300,000 convertible promissory note to its sponsor, Black Hawk Management LLC, to fund working capital expenses. The note has a 10% annual interest rate and can be converted to ordinary shares of the post-business combination company at $1.00 per share upon completion of the initial business combination.
The issuance of the convertible note to the sponsor provides additional financing for the company's operations leading up to the initial business combination, while also allowing the sponsor to convert the debt to equity in the post-combination company.
The conversion of the note to ordinary shares upon the initial business combination could result in the sponsor increasing its ownership stake in the post-combination company, which may impact the existing shareholders' equity position.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.